The therapeutic action of actarit in type II collagen-induced arthritis mice and its mechanism

Chinese Pharmaceutical Journal

Volumn 36, Issue 12, 2001, Pages 814-817

  Jin, Yong ^a   Li, Jun ^a   Zhang, Yun Fang ^a   Li, Chang Yu ^a   Xu, Shu Yun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Actari(Acta); Anti type II collagen(CII) antibodies; Type II collagen induced arthritis(CIA)

Indexed keywords

ANTIBODIES; IMMUNOLOGY; SYNTHESIS (CHEMICAL);

IMMUNITY;

DRUG THERAPY;

ACTARIT; COLLAGEN TYPE 2; INTERLEUKIN 1; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE MODEL; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; MOUSE; NONHUMAN; SPLEEN CELL;

EID: 0035729161     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Effect of actart on type II collagen induced arthritis in mice
2. Antiinflammatory properties of new antirheumatic agent 4-acetylaminophenylacetic acid
3. Clinical study of a New Anti-Rheumatic Drug, MS-932 on Rheumatoid Arthritis (Double-Blind Comparative study vs Lobenzarit Disodium)
4. Clinical study of a new anti-rheumatic drug, MS-932 on rheumatoid arthritis(open trial)
5. Collge-induced arthritis as a model of rheumatoid arthritis
6. ConA-induced proliferative respone of splenocytes from arthritic rat